Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 16Terminated 4Active not recruiting 3Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Tuberous Sclerosis 2Vascular Malformations 1Triple Negative Breast Neoplasms 1Peutz-Jeghers Syndrome 1Perivascular Epithelioid Cell Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Malignant Solid Tumors 1Lymphangioma 1Lymphangioleiomyomatosis 1Leiomyoma 1Kaposiform Hemangioendothelioma 1Hereditary Sensory and Autonomic Neuropathies 1Hematologic Neoplasms 1Hemangioendothelioma 1Graft vs Host Disease 1Epilepsy 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Advanced Solid Tumors 1

Interventions

Cyclosporine 5Cyclophosphamide 5Busulfan 4fludarabine phosphate 3fludarabine 3Mycophenolic Acid 3thymoglobulin 2Methotrexate 2Antilymphocyte Serum 2venetoclax 1trihexyltetradecylphosphonium chloride 1treosulfan 1tocilizumab 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Sirolimus 1Semustine 1Rituximab 1Radiotherapy 1Polymerase Chain Reaction 1Physical Therapy Modalities 1Peripheral Blood Stem Cell Transplantation 1Maraviroc 1Interferon alpha-2 1Immunoenzyme Techniques 1Drug Therapy 1Decitabine 1Cytarabine 1Cyclosporins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Graft vs Host Disease × Sirolimus × Clear all
NCT01428973 2024-05-09

Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens

University of Liege

Phase 2 Unknown
200 enrolled
Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡